molecular detection
              首页 > 组织芯片 > 肝 > DLV248
              tissue microarray-DLV248
              • 点数:
                24
                例数:
                12
                点样直径（mm）:
                2
                厚度（µm）:
                5
                行数:
                4
                列数:
                6
                组织阵列类型:
                FFPE
                种属:
                Human
              DLV248
              加入收藏

              描述: 含有饮酒史的肝癌及匹配肝组织组合芯片，附病理分级、TNM、临床分期和饮酒史资料，12例/24点

              详情: 含有饮酒史的肝癌及匹配肝组织组合微阵列芯片，包含肝癌及其匹配的边缘或癌旁组织8例，肝硬化2例，肝组织和非酒精性肝组织各1例，一块一点

              应用: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

              备注

              1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
              2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
              In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

              • 说明书列表
              • 重复病例
              • 下载说明书
              图表:
              Liver
              • Cirrhosis(*)
              • Malignant(II)
              • Malignant(IIIA)
              • Malignant(IVA)
              • NAT(*)
              • AT(*)
              • Normal(*)
              • _ph
              组织芯片
              DLV248
              1
              2
              3
              4
              5
              6
              A
              Liv
              Liv
              Liv
              Liv
              Liv
              Liv
              B
              Liv
              Liv
              Liv
              Liv
              Liv
              Liv
              C
              Liv
              Liv
              Liv
              Liv
              Liv
              Liv
              D
              Liv
              Liv
              Liv
              Liv
              Liv
              Liv
              _ph
              DLV248
              • 年龄:
              • 性别:
              • 器官/解剖部位:
              • 病理诊断:
              • 等级:
              • 分期:
              • 阶段:
              • 组织ID.:
              • 类型:
              POS No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Drinking amount (ml/day) Smoking time (year)
              A1
              		 1 41 M Liver Hepatocellular carcinoma 1--2 T2N0M0 II Malignant 15 300
              A2
              		 2 41 M Liver Cancer adjacent liver tissue * * * AT 15 300
              A3
              		 3 51 M Liver Hepatocellular carcinoma 3 T3N1M0 IVA Malignant 30 300
              A4
              		 4 51 M Liver Adjacent normal liver tissue * * * NAT 30 300
              A5
              		 5 55 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 20 300
              A6
              		 6 55 M Liver Adjacent normal liver tissue * * * NAT 20 300
              B1
              		 7 63 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 40 300
              B2
              		 8 63 M Liver Cancer adjacent liver tissue (cirrhosis with ballooning degeneration) * * * AT 40 300
              B3
              		 9 59 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 30 500
              B4
              		 10 59 M Liver Cancer adjacent liver tissue with ballooning degeneration * * * AT 30 500
              B5
              		 11 50 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 20 300
              B6
              		 12 50 M Liver Adjacent normal liver tissue (chronic hepatitis) * * * NAT 20 300
              C1
              		 13 37 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 10 500
              C2
              		 14 37 M Liver Adjacent normal liver tissue (cirrhosis) * * * NAT 10 500
              C3
              		 15 64 M Liver Mixed liver carcinoma * T2N1M0 IVA Malignant 40 300
              C4
              		 16 64 M Liver Cancer adjacent liver tissue (cirrhosis) * * * AT 40 300
              C5
              		 17 61 M Liver Cirrhosis with fatty degeneration * * * Cirrhosis 40 300
              C6
              		 18 61 M Liver Cirrhosis with fatty degeneration * * * Cirrhosis 40 300
              D1
              		 19 59 M Liver Nodular cirrhosis with hydropic degeneration * * * Cirrhosis 3 250-500
              D2
              		 20 59 M Liver Nodular cirrhosis with hydropic degeneration * * * Cirrhosis 3 250-500
              D3
              		 21 54 F Liver Liver tissue * * * Normal - -
              D4
              		 22 54 F Liver Liver tissue * * * Normal - -
              D5
              		 23 36 F Liver Adjacent normal liver tissue with fatty degeneration (nonalcoholic) * * * NAT - -
              D6
              		 24 36 F Liver Adjacent normal liver tissue with fatty degeneration (nonalcoholic) * * * NAT - -
              _pheochromocytoma_
              查找与该芯片存在重复病例的芯片:
              如需了解产品规格方面的任何问题，请联系我们
              西安泰博斯医药科技有限公司
              Contact us
              17792711553

              Technical Support: info@taibsbio.com

              Customer Service: info@taibsbio.com

              Address: 陕西省西安市莲湖区高新路西部国际广场1幢1单元13103室

              icp备案：陕ICP备2025085480号-1
              0.073412s